¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"minimum blocking concentration"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
minimal blocking concentration
ÃÖ¼ÒÂ÷´Ü³óµµ
autonomic blocking agent
ÀÚÀ²½Å°æÂ÷´ÜÁ¦
adrenergic blocking agent
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
blocking agent
Â÷´ÜÁ¦
blocking antibody
Â÷´ÜÇ×ü
blocking of thought
»ç°íµÎÀý
cholinergic blocking agent
Äݸ°Â÷´ÜÁ¦
ganglionic blocking agent
½Å°æÀýÂ÷´ÜÁ¦
minimum
ÃÖ¼Ò
minimum audible
µè±â¹®Åΰª, û°¢¿ªÄ¡
minimum audible field
ÃÖ¼Òû°¢¿µ¿ª
minimum audible pressure
ÃÖ¼Ò°¡Ã»À½¾Ð
minimum dose
1. ÃÖ¼Ò¿ë·® 2. ÃÖ¼Ò¼±·®
minimum essential medium
ÃÖ¼ÒÇʼö¿µ¾ç¹èÁö
minimum legible
ÃּҺи®´É
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
minimum
ÃÖ¼Ò
blocking agent
Â÷´ÜÁ¦
blocking antibody
Â÷´ÜÇ×ü
concentration
³óµµ, ÁýÁß
blood concentration
Ç÷Áß³óµµ
stress concentration
ÀÀ·ÂÁýÁß
blocking of thought
»ç°íµÎÀý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
minimal blocking concentration
ÃÖ¼ÒÂ÷´Ü³óµµ
adrenergic blocking agent
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
autonomic blocking agent
ÀÚÀ²½Å°æÂ÷´ÜÁ¦
blocking agent
Â÷´ÜÁ¦
blocking antibody
Â÷´ÜÇ×ü
cholinergic blocking agent
Äݸ°Â÷´ÜÁ¦
ganglionic blocking agent
½Å°æÀýÂ÷´ÜÁ¦
blocking test
Â÷´Ü½ÃÇè
depolarizing neuromuscular blocking drug
Å»ºÐ±Ø½Å°æ±ÙÂ÷´ÜÁ¦
ganglionic blocking drug
½Å°æÀýÂ÷´Ü¾àÁ¦
minimum legible acuity
ÃÖ¼Ò°¡µ¶½Ã·Â
minimum perceptable acuity
ÃÖ¼ÒÀÎÁö½Ã·Â
minimum separable acuity
ÃּҺи®½Ã·Â
minimum visible acuity
ÃÖ¼Ò°¡½Ã½Ã·Â
minimum audible field
ÃÖ¼Òû°¢¿µ¿ª
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
inhibitory concentration, minimum (MIC)
¾ïÁ¦ÃÖ¼Ò³óµµ
MED => minimum effective dose
ÃÖ¼ÒÈ«¹Ý·®
MED=> minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MED=£¾minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
Ganglionic blocking drugs
½Å°æÀýÂ÷´Ü¾àÁ¦(ãêÌèï½ó´Ó¨å·ð¥)
H2 recepor blocking agents, for ulcers
H2¼ö¿ëüÂ÷´ÜÁ¦(â¥é»ô÷ó´Ó¨ð¥)
alpha blocking
¾ËÆÄÂ÷´Ü
antibody, blocking
Â÷´ÜÇ×ü
ganglionic blocking action
½Å°æÀýÂ÷´ÜÀÛ¿ë.
ganglionic blocking agent
½Å°æÀýÂ÷´ÜÁ¦.
genetic blocking
À¯ÀüÀû Â÷´Ü(ë¶îîîÜó´Ó¨).
genetic blocking
À¯ÀüÀû Â÷´Ü.
receptor blocking agent
¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
AUC : area under the concentration-time curve
Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
minimum blocking concentration
ÃÖ¼ÒÂ÷´Ü³óµµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
inhibitory concentration, minimum (MIC)
¾ïÁ¦ÃÖ¼Ò³óµµ
minimum alveolar concentration
ÃÖ¼ÒÆóÆ÷³»³óµµ.
minimum anesthetic concentration
ÃÖ¼Ò¸¶Ãë³óµµ(õÌá³Ø«öÒØöô).
minimum bactericidal concentration
ÃÖ¼Ò»ì±Õ³óµµ
minimum bactericidal concentration(MBC)
minimum inhibitory concentration
ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(õÌá³Û¡ëÀîÁòÒØöô).
minimum inhibitory concentration
ÃÖ¼Ò¾ïÁ¦³óµµ
minimum inhibitory concentration
ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(̧ËÛËÑËôËøÌ¤ËÀ̬).
adrenergic blocking agent
¾Æµå·¹³¯¸°Â÷´ÜÁ¦.
adrenergic blocking agent
¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
adrenergic blocking agent
¾Æµå·¹³¯¸°(¼º) ºÀ¼â<Â÷´Ü>¾à.
alpha blocking
¾ËÆÄÂ÷´Ü
antibody, blocking
Â÷´ÜÇ×ü
autonomic blocking agent
ÀÚÀ²½Å°æÂ÷´Ü<ºÀ¼â>Á¦(í»ëÏãêÌèó´Ó¨<Üæáð>ð¥).
blocker/blocking agent
Â÷´ÜÁ¦
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½